SignatureFD’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.71M Sell
7,405
-937
-11% -$450K 0.05% 151
2026
Q1
$4.1M Buy
8,342
+96
+1% +$52.1K 0.06% 119
2025
Q4
$4.78M Buy
8,246
+365
+5% +$206K 0.07% 100
2025
Q3
$3.82M Buy
7,881
+1,173
+17% +$546K 0.06% 123
2025
Q2
$2.72M Sell
6,708
-1,459
-18% -$610K 0.05% 162
2025
Q1
$4.06M Buy
8,167
+83
+1% +$45K 0.08% 93
2024
Q4
$4.21M Sell
8,084
-487
-6% -$268K 0.08% 82
2024
Q3
$5.3M Buy
8,571
+96
+1% +$56.8K 0.1% 64
2024
Q2
$4.69M Buy
8,475
+128
+2% +$73.3K 0.1% 66
2024
Q1
$4.85M Buy
8,347
+143
+2% +$80.2K 0.1% 72
2023
Q4
$4.35M Buy
8,204
+203
+3% +$98.3K 0.1% 71
2023
Q3
$4.05M Sell
8,001
-157
-2% -$83.7K 0.11% 70
2023
Q2
$4.26M Sell
8,158
-142
-2% -$76.6K 0.11% 69
2023
Q1
$4.78M Buy
8,300
+207
+3% +$117K 0.13% 59
2022
Q4
$4.46M Sell
8,093
-264
-3% -$140K 0.13% 60
2022
Q3
$4.24M Buy
8,357
+573
+7% +$321K 0.15% 52
2022
Q2
$4.23M Buy
7,784
+310
+4% +$171K 0.14% 54
2022
Q1
$4.42M Sell
7,474
-317
-4% -$182K 0.13% 59
2021
Q4
$5.2M Buy
7,791
+730
+10% +$456K 0.16% 53
2021
Q3
$4.03M Buy
7,061
+971
+16% +$533K 0.14% 54
2021
Q2
$3.07M Buy
6,090
+384
+7% +$181K 0.12% 66
2021
Q1
$2.6M Buy
5,706
+288
+5% +$137K 0.12% 71
2020
Q4
$2.52M Sell
5,418
-493
-8% -$231K 0.12% 62
2020
Q3
$2.61M Buy
5,911
+284
+5% +$117K 0.14% 58
2020
Q2
$2.04M Buy
5,627
+576
+11% +$193K 0.12% 65
2020
Q1
$1.43M Buy
5,051
+1,391
+38% +$439K 0.12% 66
2019
Q4
$1.19M Buy
3,660
+170
+5% +$51.5K 0.09% 100
2019
Q3
$1.02M Buy
3,490
+283
+9% +$81K 0.08% 93
2019
Q2
$942K Sell
3,207
-281
-8% -$77.4K 0.08% 94
2019
Q1
$955K Buy
3,488
+625
+22% +$156K 0.08% 91
2018
Q4
$641K Buy
2,863
+207
+8% +$48.6K 0.06% 138
2018
Q3
$648K Sell
2,656
-115
-4% -$26.5K 0.07% 147
2018
Q2
$574K Buy
2,771
+540
+24% +$115K 0.06% 151
2018
Q1
$461K Buy
2,231
+740
+50% +$155K 0.05% 155
2017
Q4
$283K Buy
1,491
+138
+10% +$26.4K 0.03% 246
2017
Q3
$256K Buy
1,353
+161
+14% +$29.2K 0.03% 238
2017
Q2
$208K Buy
+1,192
New +$200K 0.03% 259
2016
Q4
Sell
-2,015
Closed -$321K 1124
2016
Q3
$321K Buy
2,015
+1,173
+139% +$181K 0.05% 154
2016
Q2
$124K Buy
842
+81
+11% +$12K 0.02% 259
2016
Q1
$108K Buy
761
+319
+72% +$42.8K 0.02% 254
2015
Q4
$63K Sell
442
-6
-1% -$800 0.01% 329
2015
Q3
$55K Buy
448
+267
+148% +$34.8K 0.01% 328
2015
Q2
$23K Buy
181
+8
+5% +$1.04K 0.01% 444
2015
Q1
$23K Buy
173
+130
+302% +$16.8K 0.01% 410
2014
Q4
$5K Buy
+43
New +$5.23K ﹤0.01% 634
2014
Q1
Sell
-379
Closed -$42K 921
2013
Q4
$42K Buy
+379
New +$37.7K 0.02% 244

Other funds holding TMO

SignatureFD's TMO Position: Q2 2026 in Review

SignatureFD reduced its Thermo Fisher Scientific (TMO) stake by 11% in Q2 2026, selling an estimated $450K and leaving 7,405 shares worth $3.71M. The position accounts for 0.05% of the portfolio, ranked #151.

SignatureFD first reported a position in TMO in Q4 2013 and has held it in 46 quarters since. The position peaked at $5.3M in Q3 2024. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • SignatureFD held 7,405 shares of Thermo Fisher Scientific worth $3.71M as of Q2 2026.
  • SignatureFD sold 937 Thermo Fisher Scientific shares in Q2 2026, an estimated $450K.
  • Thermo Fisher Scientific made up 0.05% of SignatureFD's portfolio in Q2 2026, its #151 holding.
  • SignatureFD first reported a position in Thermo Fisher Scientific in Q4 2013 and has held it in 46 quarters since.
  • SignatureFD's Thermo Fisher Scientific position peaked at $5.3M in Q3 2024.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.